Form 4: SelectQuote Director Chris Wolfe Receives RSU Grant

SelectQuote Director Chris Wolfe was granted 106,250 restricted stock units, vesting in 2026 subject to continued board service.

Summary

• Chris Wolfe, a Director and 10% Owner of SelectQuote, Inc. (SLQT), was granted 106,250 Restricted Stock Units (RSUs).
• The transaction date for this grant was November 11, 2025.
• These RSUs were granted pursuant to the Company's 2020 Omnibus Incentive Plan.
• Each RSU represents a contingent right to receive one share of SelectQuote's common stock, which has a par value of $0.01 per share.
• The RSUs will vest in full on the date of the Company's 2026 Annual Meeting of Stockholders, provided Chris Wolfe continues his service on the Board of Directors until that date.
• The reported price of the derivative security (RSU) at the time of grant was $0.00.
• Following this transaction, Chris Wolfe beneficially owns 106,250 derivative securities (RSUs) directly.

Sentiment

Score: 6

Explanation: The filing reports a routine equity grant to a director, which is generally viewed as a neutral to slightly positive event as it aligns insider interests with shareholders. It does not indicate any significant positive or negative operational or financial news.

Positives

• The grant of Restricted Stock Units to a director aligns their interests with those of the shareholders, encouraging long-term value creation.
• The equity grant is part of the company's established 2020 Omnibus Incentive Plan, indicating a structured approach to executive and director compensation.

Risks

• The vesting of the 106,250 Restricted Stock Units is contingent upon Chris Wolfe's continued service on the Company's Board of Directors until the 2026 Annual Meeting of Stockholders, posing a forfeiture risk if service ceases.

Future Outlook

The grant of Restricted Stock Units to a director indicates a continued commitment to aligning management and director incentives with long-term shareholder value. The vesting schedule through the 2026 Annual Meeting suggests an expectation of continued board stability and strategic oversight from Chris Wolfe.

Industry Context

Equity grants, such as Restricted Stock Units, are a common form of compensation for directors and executives across various industries, particularly in publicly traded companies. This practice is widely adopted to incentivize long-term performance and align the interests of company leadership with those of shareholders.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) for director compensation is a standard practice in the U.S. public company landscape, comparable to compensation structures at peers like eHealth, Inc. (EHTH) or GoHealth, Inc. (GOCO), which also utilize equity awards to incentivize their leadership.
• The vesting schedule tied to continued service is typical for such awards, ensuring retention and sustained commitment from board members, similar to governance practices observed in many S&P 500 companies.

Corporate Governance

Related Party Transactions

• The grant of Restricted Stock Units to Chris Wolfe, a Director and 10% Owner, constitutes an insider transaction, which is a form of related party dealing in the context of compensation.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial incentives with shareholder interests, potentially encouraging decisions that enhance long-term stock value.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The 106,250 Restricted Stock Units are expected to vest on the date of SelectQuote's 2026 Annual Meeting of Stockholders, subject to the director's continued service.

Key Dates

Keywords

SelectQuote, SLQT, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Grant, Form 4